Jefferies Group LLC Amgen Inc Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Jefferies Group LLC holds 75,480 shares of AMGN stock, worth $22.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

75,480

Previous 2,001 3672.11%

Holding current value

$22.2 Million

Previous $486,000 3400.62%

% of portfolio

0.17%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	BUY	$224.46 - $253.15 $16.5 Million - $18.6 Million	73,479 Added 3672.11%	75,480 $17 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $16.9 Million - $19.1 Million	75,427 Added 3769.47%	77,428 $17 Million
Q2 2022 Sep 21, 2023	SELL	$230.71 - $256.74 $39.7 Million - $44.1 Million	-171,898 Reduced 98.85%	2,001 $486,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $461,650 - $513,736	2,001 New	2,001 $487,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $38.3 Million - $42.3 Million	-174,467 Closed	0 $0
Q4 2021 Sep 21, 2023	SELL	$198.88 - $227.6 $8.82 Million - $10.1 Million	-44,335 Reduced 20.32%	173,899 $39.1 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $8.7 Million - $9.96 Million	-43,767 Reduced 20.06%	174,467 $39.2 Million
Q3 2021 Sep 21, 2023	BUY	$212.27 - $248.7 $4.04 Million - $4.73 Million	19,021 Added 9.55%	218,234 $46.4 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $4.04 Million - $4.73 Million	19,021 Added 9.55%	218,234 $46.4 Million
Q2 2021 Sep 21, 2023	BUY	$233.58 - $259.14 $37.4 Million - $41.5 Million	160,199 Added 410.62%	199,213 $48.6 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $37.4 Million - $41.5 Million	160,199 Added 410.62%	199,213 $48.6 Million
Q1 2021 Sep 21, 2023	SELL	$221.91 - $258.6 $16 Million - $18.6 Million	-71,966 Reduced 64.85%	39,014 $9.71 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $16 Million - $18.6 Million	-71,966 Reduced 64.85%	39,014 $9.71 Million
Q4 2020 Sep 21, 2023	BUY	$216.38 - $257.67 $7.26 Million - $8.65 Million	33,552 Added 43.33%	110,980 $25.5 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $22.7 Million - $27 Million	104,970 Added 1746.59%	110,980 $25.5 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $2.92 Million - $3.25 Million	-12,445 Reduced 67.43%	6,010 $1.53 Million
Q2 2020 Nov 02, 2020	BUY	$197.81 - $242.74 $3.65 Million - $4.48 Million	18,455 New	18,455 $4.35 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $7.89 Million - $9.69 Million	-39,900 Closed	0 $0
Q1 2020 Nov 24, 2020	BUY	$182.24 - $241.7 $7.27 Million - $9.64 Million	39,900 New	39,900 $8.32 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $2.57 Million - $3.41 Million	-14,100 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $3.26 Million - $4.2 Million	-17,255 Reduced 55.03%	14,100 $3.4 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $8.73 Million - $10.5 Million	-50,145 Reduced 61.53%	31,355 $6.07 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $13.4 Million - $15.7 Million	80,350 Added 6986.96%	81,500 $15 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $1.81 Million - $2.04 Million	-9,988 Reduced 89.67%	1,150 $218,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $851,860 - $994,393	4,775 Added 75.04%	11,138 $2.17 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $18,899 - $21,306	-102 Reduced 1.58%	6,363 $1.32 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $11.5 Million - $12.9 Million	-69,262 Reduced 91.46%	6,465 $1.19 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $4.54 Million - $5.31 Million	26,819 Added 54.84%	75,727 $12.9 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.26 Million - $1.41 Million	7,468 Added 18.02%	48,908 $8.51 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $6.93 Million - $7.92 Million	41,440	41,440 $7.73 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Amgen Inc Transaction History